Tumor Immunology

About Tumor Immunology

Antibodies, proteins, and assay kits for studying how the immune system recognizes tumors and how tumors evade it — the biology underlying modern cancer immunotherapy. The category covers immune-checkpoint molecules (PD-1, PD-L1, CTLA-4, LAG-3, TIM-3), tumor-infiltrating lymphocyte and myeloid markers, cytokines and chemokines of the tumor microenvironment, and antigen-presentation components. Use it to source validated reagents for checkpoint biology, immune-cell profiling, and immuno-oncology model systems across human and preclinical species.